146 related articles for article (PubMed ID: 4059796)
1. Procollagen-type III peptide serum concentrations in alcoholic and non-alcoholic liver disease.
Monarca A; Petrini C; Perolini S; Pozzi F; Adelasco L; Natangelo R; Croce G
Ric Clin Lab; 1985; 15(2):167-71. PubMed ID: 4059796
[TBL] [Abstract][Full Text] [Related]
2. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
3. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?
Surrenti C; Casini A; Milani S; Ambu S; Ceccatelli P; D'Agata A
Dig Dis Sci; 1987 Jul; 32(7):705-9. PubMed ID: 3595382
[TBL] [Abstract][Full Text] [Related]
4. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
5. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease.
Nouchi T; Worner TM; Sato S; Lieber CS
Alcohol Clin Exp Res; 1987 Jun; 11(3):287-91. PubMed ID: 3307495
[TBL] [Abstract][Full Text] [Related]
6. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
7. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload.
Colombo M; Annoni G; Donato MF; Conte D; Martines D; Zaramella MG; Bianchi PA; Piperno A; Tiribelli C
Hepatology; 1985; 5(3):475-9. PubMed ID: 3997075
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease.
Savolainen ER; Goldberg B; Leo MA; Velez M; Lieber CS
Alcohol Clin Exp Res; 1984; 8(4):384-9. PubMed ID: 6385761
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of serum type III procollagen aminopeptide with RIA-gnost PIIIP coated tube: changes in patients with various alcoholic liver diseases after abstinence].
Maruyama K; Okazaki I; Takagi T; Takahashi H; Okuyama K; Horie Y; Takagi S; Kohno H; Sato S; Ishii H
Kaku Igaku; 1992 Feb; 29(2):151-7. PubMed ID: 1564787
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.
Tanaka Y; Minato Y; Hasumura Y; Takeuchi J
Dig Dis Sci; 1986 Jul; 31(7):712-7. PubMed ID: 3720468
[TBL] [Abstract][Full Text] [Related]
11. Steroid treatment lowers hepatic fibroplasia, as explored by serum aminoterminal procollagen III peptide, in chronic liver disease.
Ballardini G; Faccani A; Bianchi FB; Fallani M; Patrono D; Capelli M; Pisi E
Liver; 1984 Dec; 4(6):348-52. PubMed ID: 6521615
[TBL] [Abstract][Full Text] [Related]
12. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
[TBL] [Abstract][Full Text] [Related]
13. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity].
García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469
[TBL] [Abstract][Full Text] [Related]
14. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.
Frei A; Zimmermann A; Weigand K
Hepatology; 1984; 4(5):830-4. PubMed ID: 6479851
[TBL] [Abstract][Full Text] [Related]
16. Procollagen III peptide levels in alcoholic liver disease and primary biliary cirrhosis.
van Zanten RA; van Leeuwen RE; Beukers R; Wilson JH
Neth J Med; 1988 Jun; 32(5-6):278-84. PubMed ID: 3393256
[No Abstract] [Full Text] [Related]
17. Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers.
Annoni G; Colombo M; Cantaluppi MC; Khlat B; Lampertico P; Rojkind M
Hepatology; 1989 May; 9(5):693-7. PubMed ID: 2707736
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases.
Chang TT; Lin HC; Lee SD; Tsai YT; Lee FY; Jeng FS; Wu JC; Yeh PS; Lo KJ
Scand J Gastroenterol; 1989 Jun; 24(5):533-8. PubMed ID: 2762752
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
20. Liver fibrosis in alcoholics. Detection by Fab radioimmunoassay of serum procollagen III peptides.
Sato S; Nouchi T; Worner TM; Lieber CS
JAMA; 1986 Sep; 256(11):1471-3. PubMed ID: 3747065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
